Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is It Too Late to Buy Ocugen Stock?

TheMotleyFool

0 0

Biotech company Ocugen (NASDAQ: OCGN) looks to be in an endless tailspin these days. Not only has its share price been cut in half in 2022, but over the past 12 months its value has crumbled to just one-fifth of what it was this time last year. The hype and excitement has left the stock as the bears appear to be out in full force.

Hope may not be entirely gone, but it's certainly fleeting for this once-promising growth stock. The company recently announced some positive news that could bring in revenue for its business this year. Can Ocugen turn things around and become a good investment for your portfolio, or is it simply too late to consider the stock?

Image source: Getty Images.

Source Fool.com

Like: 0

OCGN

Share